Immatics NV
NASDAQ:IMTX

Watchlist Manager
Immatics NV Logo
Immatics NV
NASDAQ:IMTX
Watchlist
Price: 5.3 USD -1.3% Market Closed
Market Cap: 632.6m USD

Wall Street
Price Targets

IMTX Price Targets Summary
Immatics NV

Wall Street analysts forecast IMTX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IMTX is 16.54 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

Lowest
Price Target
13.13 USD
148% Upside
Average
Price Target
16.54 USD
212% Upside
Highest
Price Target
21 USD
296% Upside
Immatics NV Competitors:
Price Targets
PBYI
Puma Biotechnology Inc
30% Upside
RLAY
Relay Therapeutics Inc
553% Upside
MAAT
Maat Pharma SA
200% Upside
SANN
Santhera Pharmaceuticals Holding AG
74% Upside
ALKS
Alkermes Plc
14% Upside
CPRX
Catalyst Pharmaceuticals Inc
47% Upside
CDMO
Avid Bioservices Inc
2% Upside
RXRX
Recursion Pharmaceuticals Inc
39% Upside

Revenue
Forecast

Revenue Estimate
Immatics NV

For the last 4 years the compound annual growth rate for Immatics NV's revenue is 31%. The projected CAGR for the next 4 years is 6%.

31%
Past Growth
6%
Estimated Growth
Estimates Accuracy
3%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Immatics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Immatics NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IMTX's stock price target?
Price Target
16.54 USD

According to Wall Street analysts, the average 1-year price target for IMTX is 16.54 USD with a low forecast of 13.13 USD and a high forecast of 21 USD.

What is Immatics NV's Revenue forecast?
Projected CAGR
6%

For the last 4 years the compound annual growth rate for Immatics NV's revenue is 31%. The projected CAGR for the next 4 years is 6%.

Back to Top